THE Hamilton Medical Group has been recognised for its involvement in a new clinical study for the elderly.
ASPREE (ASPirin in Reducing Events in the Elderly), is a major international study which will determine whether taking aspirin can help maintain good health in people aged over 70.
It’s the largest aspirin primary prevention trial ever undertaken in older Australians, with researchers hoping the study will determine whether aspirin can prevent or delay the onset of various diseases common in old age.
“What ASPREE is doing is trying to find out whether taking a low dose aspirin is going to be a good thing for people as they age, to reduce the incidents of diseases such as heart attacks, stroke, dementia and cancer, which become more prevalent as they age,” said Julie Battistello, a Senior Research Nurse for ASPREE.
Led by Monash University in Melbourne and supported locally by the South West Alliance of Rural Health, the study currently has 120 participants in Hamilton, the highest of any clinics in the region.
Full story in The Spectator on Tuesday, April 8, 2014, or subscribe to our epaper at top of page.